TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
KARD

Kardigan, Inc.

Healthcare · Biotechnology

14.30$ -3.4% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

Kardigan, Inc. (KARD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement KARD
Line item Q1 25 Q2 25 Q1 26 Q2 26
0.0 0.0 0.0 0.0
– – – 2.2
– – – -2.2
19 36 45 55
7.3 21 14 19
26 57 59 73
-26 -57 -59 -75
-22 -57 -56 -116
-18 -57 -56 -116
-25 -56 -57 -73

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?